Market Tracker

12/09 5:16pm ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

45.57
Delayed Data
As of 4:00pm ET
 -0.99 / -2.13%
Today’s Change
19.59
Today|||52-Week Range
62.68
-26.42%
Year-to-Date
The 3 Best Biotech Stocks for 2017
Dec 08 / MotleyFool.com - Paid Partner Content
4 Factors That Catapulted Ionis Pharmaceuticals Inc. 68% Higher in November
Dec 04 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close46.56
Today’s open46.75
Day’s range45.38 - 47.49
Volume1,227,577
Average volume (3 months)2,193,029
Market cap$5.6B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-51.58%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book27.91

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-0.18-0.14%
MNKMallinckrodt Plc+0.25+0.48%
VRXValeant Pharmaceutic...+0.02+0.13%
OPKOPKO Health Inc+0.16+1.48%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts